Our results indicated inhibition of the IL-6/gp130/STAT3 pathway accompanied with the alleviation of the pathological remodeling and heart failure induced by pressure overload; therefore, we thought that the intervention of IL-6/STAT3 signal by raloxifene might involve the pivotal mechanism of the remission. The gene discussed is STAT3; the disease is heart failure.